Products
Latest Partnered Companies
Projects
Estimated Cost :
$19 million
Summit Biosciences to invest $19 million in it's production at Lexington, Kentucky
Summit Biosciences Inc., a pharmaceutical company focused on nasal spray medicines, is expanding its operation at the University of Kentucky Coldstrea...
Estimated Cost :
€25 million
Evonik Expands Dossenheim and Hanau Sites in Germany
Evonik has announced plans for the expansion of its Dossenheim and Hanau facilities in Germany in order to meet the increasing pharmaceutical demand f...
Estimated Cost :
-
FUJIFILM Diosynth Biotechnologies to Construct New Biocampus in UK
FUJIFILM Diosynth Biotechnologies (FDB)unveiled its plans for the construction of a new BioCampus
Estimated Cost :
€610 million
Sanofi to invest €610 million to Build a New World Class Research Centre
Sanofi plans to build a world class vaccine production site and a new research centre dedicated for the development
Press Release
Aerogen collaborates in the development of more than 15 potential inhalation therapies for COVID-19
Aerogen , the world leader in aerosol drug delivery systems, announced the details of a large collaborative effort to support pharmaceutical companies around the world as they work to develop COVID-19 treatments and vaccines.
Adaptive Phage Therapeutics Receives Orphan Drug Designation for PhageBank™ in Prosthetic Joint Infections
Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat the global rise of multi-drug resistant infectious diseases, announced the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies
Poseida Therapeutics, Inc, a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cure, and TScan Therapeutics, Inc.,
Salk Institute and BridgeBio Pharma Collaborate to Advance Therapies for Genetically Driven Disease
The Salk Institute and BridgeBio Pharma, Inc. announced a three-year collaboration agreement formed to advance cutting-edge academic discoveries in genetically driven diseases toward therapeutic applications.
Events
2nd International Women Health and Breast Cancer Conference
7th Pre Filled Syringes East Coast
International Conference on Nanomedicine and Drug Delivery Systems 2020
Articles
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Next-Generation Biological Therapeutics Discovery & Development
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Advertisements
See your banner here...
